Vancouver, British Columbia, June 9, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE: LEXT) (OTCQB: LEXTF) announces that its subsidiaries Egret Bioscience Ltd. and Zenalytic Laboratories Ltd. (the “Subsidiaries”) will be laying off all their employees effective June 15, 2022. The decision was made due to the lack of profitability and to save costs. Some scientific staff will be available on as needed basis. The Company is planning the future for the Subsidiaries.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.